Skip to content

Clinical trials

Completed Phase 2 Respiratory Distress Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Distress Syndrome Phase: Phase 2 Status: Completed Clear all

56 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20043
20051
20063
20072
20083
20092
20102
20111
20123
20131
20142
20151
20171
20193
202019
20215
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed56

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Windtree Therapeutics3
GlaxoSmithKline2
Mayo Clinic2
Michael A. Matthay2
University of Minnesota2
Abraham Edgar Gracia-Ramos1
Acticor Biotech1
Aerogen Pharma Limited1
Albert Einstein College of Medicine1
Altor BioScience1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Distress Syndrome56
COVID-1918
Acute Lung Injury16
Severe Acute Respiratory Syndrome6
Respiratory Insufficiency5
Coronavirus Infections4
Sepsis4
Bronchopulmonary Dysplasia2
Cytokine Release Syndrome2
Lung Diseases2

Trials

Showing 1 to 25 of 56. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.